GLPG - GALAPAGOS NV

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 34.51

Open

$ 34.04

Bid

$ 33.00 x 1

Ask

$ 35.42 x 100

Day's Range

$ 33.88 - $ 34.62

52 Week Range

$ 22.36 - $ 37.78

Volume

137,100

Average Volume

Market Cap

2.27B

Beta (5Y Monthly)

$ 0.63

PE Ratio (TTM)

$ 15.14

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Galapagos Says As Of Today's Date, The Boa...
10/01/2025 20:03:40

Galapagos NV Advances Cell Therapy Busines...
10/01/2025 20:02:59

Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV ((Euronext &, NASDAQ:GLPG) and its Board of Directors today iss...

$galapagos-receives-fda-rmat-designation-for-glpg5101-as-anti-cd194-1bb-car-t-therapy-targeting-relapsedrefractory-mantle-cell-lymphoma$

Galapagos Receives FDA RMAT Designation Fo...
08/06/2025 06:39:21

tesla-posts-downbeat-earnings-joins-community-health-systems-chipotle-mexican-grill-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

Tesla Posts Downbeat Earnings, Joins Commu...
07/24/2025 12:36:13

why-alphabet-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Why Alphabet Shares Are Trading Higher; He...
07/24/2025 09:23:22

Galapagos Q2 EPS $(1.45) Misses $(0.09) Es...
07/23/2025 20:20:49

Galapagos (NASDAQ:GLPG) reported quarterly losses of $(1.45) per share which missed the analyst consensus estimate of $(0.09) b...

Earnings Scheduled For July 23, 2025
07/23/2025 08:32:26

Galapagos Appoints Aaron Cox As Chief Fina...
06/23/2025 06:35:51

$galapagos-reports-97-complete-response-rate-with-glpg5101-in-phase-12-atalanta-1-trial-for-relapsedrefractory-inhl$

Galapagos Reports 97% Complete Response Ra...
06/18/2025 20:02:51

Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CA...

$galapagos-reports-safety-data-from-atalanta-1-phase-12-study-of-cd19-car-t-therapy-in-relapsedrefractory-nhl-highlighting-low-high-grade-toxicity-95-use-of-fresh-cells-and-rapid-7-day-turnaround-enabled-by-decentralized-manufacturing$

Galapagos Reports Safety Data From ATALANT...
06/12/2025 20:02:00

Galapagos Announces New Data From ATALANTA...
05/14/2025 20:05:07

Galapagos Re-Evaluates Proposed Separation...
05/13/2025 05:51:14

Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments...

Galapagos Q1 2025 GAAP EPS $(2.47) Down Fr...
04/23/2025 20:07:07

Galapagos (NASDAQ:GLPG) reported quarterly losses of $(2.47) per share. This is a 262.57 percent decrease over earnings of $1.5...

Earnings Scheduled For April 23, 2025
04/23/2025 08:32:28

Uncovering Potential: Galapagos's Earnings...
04/22/2025 21:01:50

Galapagos CFO And COO Thad Huston To Depar...
04/15/2025 06:22:11

Galapagos Receives Transparency Notificati...
02/17/2025 23:18:53

Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on February 14, 2025 on behalf of...

Morgan Stanley Downgrades Galapagos to Und...
02/14/2025 18:06:45

Morgan Stanley analyst Judah Frommer downgrades Galapagos (NASDAQ:GLPG) from Equal-Weight to Underweight and lowers the pric...

Galapagos Q4 EPS $0.30, Sales $80.58M (Con...
02/12/2025 21:23:55

Galapagos (NASDAQ:GLPG) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $(0.35) by ...

Galapagos Intends To Separate Into Two Pub...
02/12/2025 21:08:56